Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 35 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 7687642

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  2. US 7683080

    Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  3. US 7683177

    Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  4. US 7678799

    Crystalline ziprasidone HCl and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  5. US 7678938

    Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  6. US 7678816

    Method of stabilizing lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  7. US 7674935

    Crystal forms of O-desmethylvenlafaxine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  8. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  9. US 7674480

    Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted
  10. US 7671071

    Polymorphic Form XVI of fexofenadine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted
  11. US 7666989

    Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted
  12. US 7662800

    Hyaluronic acid derivatives

    Jasper Ltd. Liability Co. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  13. US 7655781

    Variants of human glycoprotein hormone alpha chain: compositions and uses thereof

    Protalix Ltd. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  14. US 7632841

    2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted
  15. US 7629458

    Preparation of levofloxacin and hemihydrate thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  16. US 7622588

    Method for the purification of lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  17. US 7619112

    Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  18. US 7618976

    Methods for the production of sildenafil base and citrate salt

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  19. US 7619117

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  20. US 7611722

    Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  21. US 7612203

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  22. US 7605274

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  23. US 7605290

    Processes for the synthesis of O-desmethylvenlafaxine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  24. US 7598396

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted